Literature DB >> 333025

Complement receptors in human renal glomeruli. Further evidence by immunofluorescence.

J F Girard, K Ayed, P Druet.   

Abstract

A new method is described for demonstrating the presence of glomerular receptors for the third component of complement in human kidney. Frozen sections are incubated together with normal human serum and inulin. Activated C3 is detected by a fluoresceinated anti-C3 antiserum. Glomeruli are labelled by C3-coated inulin particles while there is no labelling in tubules and interstitium. This method is easy and rapid and it allows the exact localization of C3 glomerular receptors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 333025     DOI: 10.1016/0022-1759(77)90070-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Tissue C3b receptors.

Authors:  L Schrieber; R Penny
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

2.  IgG Fc membrane receptor on normal human glomerular visceral epithelial cells.

Authors:  R Mancilla-Jimenez; M D Appay; B Bellon; J Kuhn; J Bariety; P Druet
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

Review 3.  Factors influencing immune complex localisation.

Authors:  L Schrieber; R Penny
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

Review 4.  Viral infections, their influence on some parts of the immune system and glomerulonephritis development.

Authors:  A Steciwko
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

5.  Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.

Authors:  H H Sedlacek
Journal:  Klin Wochenschr       Date:  1980-06-16

6.  Deposits of immunoglobulins and C3 in the walls of human renal arteries.

Authors:  Y A Mekori; P Steiner; R Farkash; T Moalem; A Klajman
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.